Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis.

Autor: Morgan SJ; Departments of Microbiology and Medicine, University of Washington, Seattle, Washington, USA., Nichols DP; Cystic Fibrosis Foundation, Bethesda, Maryland, USA., Ni W; Departments of Microbiology and Medicine, University of Washington, Seattle, Washington, USA., Hong G; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Salipante SJ; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Solomon GM; Department of Medicine, University of Alabama, Birmingham, Alabama, USA; and., Rowe SM; Cystic Fibrosis Foundation, Bethesda, Maryland, USA.; Department of Medicine, University of Alabama, Birmingham, Alabama, USA; and., Clancy JP; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Cramer RA; Department of Microbiology and Immunology, Dartmouth Geisel School of Medicine , Hanover, New Hampshire, USA., Singh PK; Departments of Microbiology and Medicine, University of Washington, Seattle, Washington, USA.
Jazyk: angličtina
Zdroj: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 Nov 01; Vol. 210 (9), pp. 1155-1158.
DOI: 10.1164/rccm.202406-1128RL
Databáze: MEDLINE